A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia
Open accessAbstract
Objectives Few centers have adopted endovascular therapy for the treatment of acute mesenteric ischemia (AMI). We sought to evaluate the effect of endovascular therapy on outcomes for the treatment of AMI.Methods A single-center, retrospective cohort review was performed on all consecutive patients with thrombotic or embolic AMI presenting between 1999 and 2008. Patients with mesenteric venous thrombosis, nonocclusive mesenteric ischemia, and ischemia associated with aortic dissection were excluded. Demographic factors, preoperative metabolic status, and etiology were compared. Primary clinical outcomes included endovascular technical success, operative complications, and in-hospital mortality.Results Seventy consecutive patients were identified with AMI (mean age, 64 ± 13 years). Etiology of mesenteric ischemia was 65% thrombotic and 35% embolic occlusions. Endovascular revascularization was the preferred treatment (81%) vs operative therapy (19%). Successful endovascular treatment was achieved in 87%. Endovascular therapy required laparotomy in 69% vs traditional therapy in 100% (P < .05), with a median 52-cm necrotic bowel resected (interquartile range [IQR], 11-140 cm) vs 160 cm (IQR, 90-250 cm; P < .05), respectively. Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05). Successful endovascular treatment resulted in a mortality rate of 36% compared with 50% (P < .05) with traditional therapy, whereas the mortality rate for endovascular failures was 50%. Endovascular therapy was associated with improved mortality in thrombotic AMI (odds ratio, 0.10; 95% confidence interval, 0.10-0.76; P < .05).Conclusions Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach. Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 16 cited sources checked · 0 supported · 0 flagged
- Findingown data
Necrotic bowel requiring resection negatively affected overall mortality.
“riod, the maximum lactate level and necrotic bowel requiring resection also negatively affected overall mortality.”
Quote in the paperNot a substantial claim - Findingown data
The endovascular failure subgroup did not have a greater risk of death than patients treated with traditional therapy.
“This subgroup group did not experience any risk of death greater than those who underwent traditional therapy.”
Quote in the paperSubstantial claim - Findingown data
Overall technical success for endovascular therapy was 87%.
“Successful endovascular treatment was achieved in 87%.”
Quote in the paperSubstantial claim - Findingown data
Endovascular failures had a mortality rate similar to traditional therapy (50% vs 50%).
“endovascular failures approached the mortality rate of traditional therapy (50% vs 50%).”
Quote in the paperSubstantial claim - Findingown data
Postoperative pulmonary failure was significantly associated with death.
“In the postoperative period, acute renal failure and pulmonary failure were significantly associated with death.”
Quote in the paperNot a substantial claim
- Findingown data
Duration of symptoms did not correlate with technical success (median 36; IQR 16-130 hours for successes vs median 48; IQR 24-84 hours for failures; P = .20).
“Duration of symptoms did not correlate with technical success (median, 36; IQR, 16-130 hours) compared with failures (median, 48; IQR, 24-84 hours; P ϭ .20).”
Quote in the paperNot a substantial claim - Findingown data
Overall mortality was 39% for endovascular therapy versus 50% for traditional therapy (P = .10).
“The overall mortality was 39% for endovascular therapy vs 50% for traditional therapy (P ϭ .10).”
Quote in the paperSubstantial claim - Findingown data
Endovascular therapy required laparotomy in 69% of patients, compared with 100% for traditional therapy (P < .05).
“Endovascular therapy required laparotomy in 69% vs traditional therapy in 100% (P < .05)”
Quote in the paperSubstantial claim - Findingown data
Technical success did not differ between thrombotic and embolic disease (89% vs 85%; P = .94).
“An evaluation of factors associated with endovascular success found no differences in thrombotic (89%) vs embolic disease (85%; P ϭ .94)or in proximal occlusions (85%) vs distal occlusions (93%; P ϭ .79).”
Quote in the paperNot a substantial claim - Findingown data
An initial lactate level >2.2 mmol/L was associated with an increased risk of death.
“At the time of presentation, increasing age, history of coronary artery disease, peripheral arterial disease, and initial lactate Ͼ2.2 mmol/L were associated with increased risk of death.”
Quote in the paperNot a substantial claim - Findingown data
In this series, patients treated with endovascular therapy presented with a median of 62 hours of symptoms, much longer than patients treated with traditional therapy.
“In this series, patients treated with endovascular therapy presented with a median of 62 hours of symptoms, which was much longer than those undergoing traditional therapy.”
Quote in the paperSubstantial claim - Findingown data
No measurable deleterious effects of endovascular therapy were identified in this cohort.
“No measurable deleterious effects of endovascular therapy were identified within this cohort.”
Quote in the paperSubstantial claim - Findingown data
Overall, endovascular therapy was not associated with a survival benefit.
“Overall, endovascular therapy was not associated with a survival benefit.”
Quote in the paperSubstantial claim - Findingown data
A history of coronary artery disease was associated with an increased risk of death.
“At the time of presentation, increasing age, history of coronary artery disease, peripheral arterial disease, and initial lactate Ͼ2.2 mmol/L were associated with increased risk of death.”
Quote in the paperNot a substantial claim - Findingown data
Acute renal failure occurred less frequently with endovascular therapy than with traditional therapy (27% vs 50%; P < .05).
“Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05).”
Quote in the paperSubstantial claim - Findingown data
Increasing age was associated with an increased risk of death.
“At the time of presentation, increasing age, history of coronary artery disease, peripheral arterial disease, and initial lactate Ͼ2.2 mmol/L were associated with increased risk of death.”
Quote in the paperNot a substantial claim - Findingown data
Postoperative complications occurred more frequently with traditional therapy.
“Postoperative complications occurred more frequently with traditional therapy (Table III).”
Quote in the paperSubstantial claim - Findingown data
In this population, the etiology of occlusion did not affect mortality.
“Despite these differences, the etiology of occlusion did not affect the mortality rate in our population.”
Quote in the paperSubstantial claim - Findingown data
Procedural time for endovascular revascularization was essentially identical to traditional therapy.
“Procedural time for endovascular revascularization was essentially identical to traditional therapy.”
Quote in the paperSubstantial claim - Findingown data
Postoperative acute renal failure was significantly associated with death.
“In the postoperative period, acute renal failure and pulmonary failure were significantly associated with death.”
Quote in the paperNot a substantial claim - Findingown data
During the 9-year study period, 70 patients with acute mesenteric ischemia from thrombotic or embolic arterial occlusions were treated.
“During the 9-year study period, 70 patients with AMI secondary to thrombotic or embolic arterial occlusions were treated.”
Quote in the paperSubstantial claim - Findingown data
Endovascular therapy significantly reduced mortality for thrombotic occlusions (33% vs 83%; OR 0.10; 95% CI 0.17-0.76; P < .05).
“however, endovascular therapy significantly reduced the mortality for thrombotic occlusions (mortality, 33%; odds ratio, 0.10; 95% confidence interval, 0.17-0.76;P Ͻ .05)compared with traditional therapy (mortality, 83%).”
Quote in the paperSubstantial claim - Findingown data
Technical success did not differ between proximal and distal occlusions (85% vs 93%; P = .79).
“An evaluation of factors associated with endovascular success found no differences in thrombotic (89%) vs embolic disease (85%; P ϭ .94)or in proximal occlusions (85%) vs distal occlusions (93%; P ϭ .79).”
Quote in the paperNot a substantial claim - Findingown data
Duration of symptoms before treatment was markedly longer in patients treated with endovascular therapy (median 62 vs 26 hours; P < .05).
“Duration of symptoms before treatment was markedly longer in the patients treated with endovascular therapy (median, 62 vs 26 hours; P Ͻ .05).”
Quote in the paperNot a substantial claim - Findingown data
In this series, 31% of patients treated with endovascular therapy avoided laparotomy altogether.
“31% of patients treated with endovascular therapy avoided laparotomy altogether.”
Quote in the paperSubstantial claim - Findingown data
Patients successfully treated with endovascular therapy had a lower mortality rate (36%) than those treated traditionally (50%; P < .05).
“Patients who were successfully treated with endovascular therapy experienced a significant reduction in mortality (36%) compared with traditional therapy (50%; P Ͻ .05).”
Quote in the paperSubstantial claim - Findingown data
Duration of abdominal symptoms did not affect the likelihood of endovascular success.
“Duration of abdominal symptoms also did not affect the likelihood of endovascular success.”
Quote in the paperSubstantial claim - Findingown data
Pulmonary failure occurred less frequently with endovascular therapy than with traditional therapy (27% vs 64%; P < .05).
“Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05).”
Quote in the paperSubstantial claim - Findingown data
A history of peripheral arterial disease was associated with an increased risk of death.
“At the time of presentation, increasing age, history of coronary artery disease, peripheral arterial disease, and initial lactate Ͼ2.2 mmol/L were associated with increased risk of death.”
Quote in the paperNot a substantial claim - Findingown data
Maximum lactate level negatively affected overall mortality.
“riod, the maximum lactate level and necrotic bowel requiring resection also negatively affected overall mortality.”
Quote in the paperNot a substantial claim - Findingown data
Technical success for partial occlusions was 100% compared with 82% for complete occlusions (P = .18).
“The technical success for partial occlusions was 100% compared with 82% for complete occlusions (P ϭ .18).”
Quote in the paperNot a substantial claim - Findingown data
Subgroup analysis showed no significant mortality difference for embolic occlusions between endovascular therapy (53%) and traditional therapy (33%; P = .20).
“Subgroup analysis demonstrated that there was no significant difference in mortality for embolic occlu-sions for endovascular therapy (53%) vs traditional therapy (33%; P ϭ .20);”
Quote in the paperSubstantial claim - Findingown data
In this series, 81% of patients were treated with endovascular therapy first.
“Eighty-one percent of the patients were chosen to undergo endovascular therapy first.”
Quote in the paperNot a substantial claim - Findingown data
Laparotomy rate was around 68% to 72% in all infusion subgroups.
“Their laparotomy rate was around 68% to 72% in all of those subgroups.”
Quote in the paperNot a substantial claim - Interpretationreasoning
These factors were associated with lower mortality in the endovascular group.
“All of these factors were associated with a lower mortality rate in this group.”
Quote in the paperSubstantial claim - Interpretationreasoning
Differences in etiology between treatment groups are partly explained by the institution's evolving treatment paradigm.
“Disparities in etiologies across the two groups are partially attributable to progression in the treatment paradigm at our institution.”
Quote in the paperNot a substantial claim - Interpretationown data
This study is the largest reported series of patients with acute mesenteric ischemia treated with endovascular therapy to date.
“to date, this study represents the largest series of patients with AMI treated with endovascular therapy.”
- Also stated in: § DISCUSSION · plain
“This represents the largest single-center experience using endovascular therapy for the treatment of AMI.”
Quote in the paperSubstantial claim- Rests on an assumption: Acute mesenteric ischemia is relatively infrequent, making it difficult for a single center to accumulate a large experience in a short period.
- Also stated in: § DISCUSSION · plain
- Interpretationreasoning
The observed relationship between abdominal pain and outcomes may be explained by variability in pain relative to tolerance of intestinal ischemia, prior visceral atherosclerosis, collateralization, and occlusion location.
“These results can be explained by the variability in abdominal pain in relationship to tolerance of intestinal ischemia, prior visceral atherosclerosis, degrees of collater-”
Quote in the paperSubstantial claim - Interpretationown data
The results contradict prior reports that longer duration of abdominal pain predicts worse prognosis.
“Our results contradict previous reports demonstrating duration of abdominal pain portending a worse prognosis.5,13”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Kassahun, 2008, Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review, Langenbecks Arch Surg source
Not checked in the free run.
- cites [13] Acosta, 2005, Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients, Ann Surg source
Not checked in the free run.
- Premisecitation
In that reported hybrid group, mortality was 17% compared with 80% in patients treated with open revascularization during the same period.
“The mortality rate was 17% in the hybrid group compared with 80% in the patients treated with open revascularization during the same period.12”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Wyers, 2007, Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia, J Vasc Surg source
Not checked in the free run.
- Interpretationreasoning
Previous case reports and small series reporting 0% to 17% mortality for endovascular therapy are largely affected by reporting bias.
“Previous case reports and small series that report mortality rates of 0% to 17% 10,12 for endovascular therapy are largely subject to reporting bias.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [10] Schoots, 2005, Thrombolytic therapy for acute superior mesenteric artery occlusion, J Vasc Interv Radiol source
Not checked in the free run.
- cites [12] Wyers, 2007, Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia, J Vasc Surg source
Not checked in the free run.
- Study design and conductreasoning
Classification of etiology relied on surgeon interpretation of clinical presentation, radiographic findings, and operative findings, making this variable subject to error.
“The classification of etiology relied on surgeon interpretation of the clinical presentation, radiographic findings, and operative findings, subjecting this variable to error.”
Quote in the paperNot a substantial claim- Rests on an assumption: The variability and error in determining exact etiology is uniform across articles reporting outcomes for acute mesenteric ischemia.
- Premisecitation
The largest available series of open retrograde stenting for acute mesenteric ischemia involved six patients.
“The largest series available for open retrograde stenting in the setting of AMI involved six patients.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Wyers, 2007, Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia, J Vasc Surg source
Not checked in the free run.
- Study design and conductnone given
The current report includes all consecutive patients with acute mesenteric ischemia treated over 9 years at a large multidisciplinary referral center.
“The current report offers a complete representation of all consecutive patients treated with AMI during the past 9 years at a large multidisciplinary referral center”
Quote in the paperSubstantial claim - Study design and conductown data
Examining all measurable covariates, no specific reasons for selection bias other than surgeon preference could be differentiated.
“Examining all measurable covariates, we couldn't differentiate any specific reasons for bias other than surgeon preference.”
Quote in the paperNot a substantial claim - Interpretationown data
Successful endovascular therapy confers a survival advantage in this moribund population.
“successful endovascular therapy portends a survival advantage in this moribund population.”
Quote in the paperSubstantial claim
- May combine two claims. 34
- Classified as probably not a substantial claim. 27
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataThe endovascular cohort had more thrombotic occlusions (72%), while the traditional cohort had more embolic occlusions (64%).
“In addition, the endovascular cohort was weighted with more thrombotic occlusions (72%) compared with the traditional cohort, which was weighted with more embolic occlusions (64%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEndovascular failures resulted in a 50% mortality rate, similar to traditional therapy.
“Endovascular failures resulted in a 50% mortality rate, similar to traditional therapy.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEndovascular therapy was initiated in 56 patients (81%), making it the preferred treatment modality for acute mesenteric ischemia during the 9-year period.
“Endovascular therapy was initiated in 56 patients (81%), representing the preferred treatment modality for acute mesenteric ischemia during this 9-year period.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere was a 9% initial endovascular failure rate and a 13% total failure rate, giving an 87% technical success rate for endovascular therapy.
“There was a 9% initial endovascular failure rate in this series, with a total failure rate of 13%, resulting in an 87% technical success rate for endovascular therapy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSuccessful endovascular therapy reduced mortality to 36% from 50%, while endovascular failure did not increase mortality.
“Although endovascular failures did not increase the mortality rate, endovascular successes reduced the mortality rate to 36% from 50%.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn this series, patients treated with endovascular therapy had a median of 60 hours of abdominal pain, and duration of symptoms less than 24 hours was only weakly associated with death.
“In the current series, patients undergoing endovascular therapy presented with a median of 60 hours of abdominal pain, and duration of symptoms Ͻ24 hours was only weakly associated with death.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPatients treated traditionally tended to have a higher admission lactate concentration (median 3.5 mmol/L) than those treated endovascularly (median 2.3 mmol/L; P = .06).
“Although not statistically significant, those with traditional therapy tended to have a slightly higher lactate concentration on admission (median, 3.5 mmol/L) compared with endovascular therapy (median, 2.3 mmol/L; P ϭ .06).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn historical context, the endovascular group had a high proportion of thrombotic occlusions (72%) but had the lowest subgroup mortality (33%).
“Taken into historical context, the endovascular group was weighted with thrombotic occlusions (72% of patients) yet resulted in the lowest subgroup mortality (33%).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenComputed tomography angiography was used in essentially all patients to secure the diagnosis, while arteriography was primarily used with endovascular treatment.
“computed tomography angiography was used in essentially all patients to secure the diagnosis, and arteriography was primarily used with endovascular treatment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe etiology was thrombotic occlusion in 65% and embolic occlusion in 35%.
“The etiology was thrombotic occlusion in 65% compared with embolic occlusion in 35%.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPatients treated with endovascular therapy were slightly older than those treated traditionally (65 ± 12 vs 60 ± 13 years; P < .05).
“Patients treated with endovascular therapy were slightly older (65 Ϯ 12 vs 60 Ϯ 13 years; P Ͻ .05).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mean age of the study population was 64 ± 13 years.
“The mean age of the population was 64 Ϯ 13 years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn this series, mortality was 36% after successful endovascular therapy and 50% after endovascular failure.
“the resultant mortality rate was 36% for successful endovascular therapy compared with 50% for failures.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataAmong patients requiring bowel resection, the median length resected was 52 cm (IQR 11-140) with endovascular therapy versus 160 cm (IQR 90-250) with traditional therapy (P < .05).
“of those requiring bowel resection, a median of 52 cm of bowel was resected compared with 160 cm for traditional therapy (P Ͻ .05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenThe age difference between treatment groups was statistically significant but clinically negligible.
“The age difference, although statistically significant, is clinically negligible.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningAt this institution, thrombotic arterial occlusions were initially treated with endovascular therapy, and embolic occlusions were treated endovascularly later as experience grew, so a larger proportion of thrombotic occlusions received endovascular therapy.
“Initially, thrombotic arterial occlusions were first approached with endovascular therapy, followed by embolic occlusions as experience matured; therefore, a larger percentage of thrombotic occlusions were treated with endovascular therapy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBleeding complications were relatively low: no hemorrhagic stroke, minor gastrointestinal bleeding, and 9% access-related bleeding.
“The bleeding complications were relatively low: These patients did not experience hemorrhagic stroke, gastrointestinal bleeding was minor, and accessrelated bleeding was 9%.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEndovascular therapy was associated with lower laparotomy rates, smaller bowel resection at surgical exploration, and lower rates of renal and pulmonary failure.
“Endovascular therapy afforded lower laparotomy rates, a significantly smaller bowel resection at the time of surgical exploration, and lower rates of renal and pulmonary failure.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAlthough selection bias is evident in this retrospective analysis, few measurable differences existed between patients treated with endovascular therapy and traditional therapy.
“Although selection bias is evident in this retrospective analysis, there were few measurable differences in patients treated with endovascular therapy compared with traditional therapy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenEndovascular failures were not associated with etiology or location of occlusion, but complete occlusions appeared to have a lower success rate than partial occlusions.
“Endovascular failures were not associated with etiology or location of occlusion, but complete occlusions appeared to have a lower success rate than partial occlusions.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn this cohort, mortality with traditional therapy was 50%, comparable to the 52% to 70% mortality reported in recent series.
“The 50% mortality of traditional therapy in our population is comparable to the mortality rate of 52% to 70% in recent reports, 1,5,11”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
Not checked in the free run.
- cites [5] Kassahun, 2008, Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review, Langenbecks Arch Surg source
Not checked in the free run.
- cites [11] Cho, 2002, Long-term outcome after mesenteric artery reconstruction: a 37-year experience, J Vasc Surg source
Not checked in the free run.
May combine two claims.
Findingown dataThere is a trend toward worse outcomes with longer infusion therapy, but subgroups are too small to draw conclusions; mortality was 40% to 45%.
“When we examined the mortality for those patients, there is a trend for worse outcomes if they undergo infusion therapy longer.These subgroups are really too small to draw any conclusions; however, the mortality is 40% to 45%.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEmbolectomy patients appear to have a higher mortality.
“the embolectomy patients appear to have a higher mortality.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningMedian time to laparotomy was 4 hours, so most patients were revascularized with endovascular techniques at the time of initial laparotomy.
“Our median time to laparotomy was 4 hours; therefore, most of these patients are revascularized with endovascular techniques at the time of their initial laparotomy.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
FindingreasoningThe only aspect that made the two groups disparate was etiology.
“The only aspect that really made the two groups disparate was the etiology.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMost patients received 1 day of infusion therapy, and about seven received 2 or more days.
“The majority of our patients received 1 day of therapy, and then there are about seven patients that received 2 or more days of infusion therapy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenMost patients remain extubated.
“Most of these patients remain extubated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf 56 patients who underwent endovascular therapy, 28 (48%) received lytic therapy.
“56 patients underwent endovascular therapy altogether, 48%, or 28 patients, underwent lytic therapy.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenEmbolic patients presented in the shortest amount of time and with the least amount of collateralization.
“they are also the ones that presented in the shortest amount of time and with the least amount of collateralization.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAcute mesenteric ischemia is a rare condition, accounting for 0.1% of hospital admissions, but it carries a very high mortality rate.
“Acute mesenteric ischemia (AMI) accounts for only 0.1% of hospital admissions but is associated with a daunting mortality rate. 1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe number of vessels occluded, location of occlusion, complete versus partial occlusion, and intraoperative adjuncts were based on the operating surgeon's dictation.
“The number of vessels occluded, location of vessel occlusion, complete vs partial occlusion, and intraoperative adjuncts were based on the operating surgeon's dictation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenThis cohort represents patients appropriately diagnosed with acute mesenteric ischemia.
“these patients represent a cohort that was appropriately diagnosed with AMI”
Quote in the paperNot a substantial claim- The authors state this as an assumption: There are unidentified cases of acute mesenteric ischemia in which the vascular surgery service did not evaluate the patient.
May combine two claims.
PremisecitationEndovascular therapy for acute mesenteric ischemia has been described only in case reports and case series, which show feasibility but leave its overall effect on outcomes largely unknown.
“Endovascular therapy has been reported for the treatment of AMI in the form of case reports and case series; these initial results demonstrate feasibility, but the overall effect on outcomes is largely unknown.9,10”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Yang, 2010, Successful recanalization of acute superior mesenteric artery thrombotic occlusion with primary aspiration thrombectomy, World J Gastroenterol source
Not checked in the free run.
- cites [10] Schoots, 2005, Thrombolytic therapy for acute superior mesenteric artery occlusion, J Vasc Interv Radiol source
Not checked in the free run.
May combine two claims.
Interpretationown dataDuration of abdominal pain did not distinguish patients who would benefit from endovascular therapy or those in whom endovascular therapy was contraindicated.
“Duration of abdominal pain did not discriminate patients who would benefit from endovascular therapy nor did it identify patients in whom endovascular therapy was prohibitive.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe etiology of occlusion (thrombotic or embolic) was determined from operative dictation and based on surgeon interpretation of clinical presentation, radiographic findings, and operative findings, so it should be interpreted in that context.
“The determination of etiology (thrombotic or embolic) was based on the operative dictation of treatment.The classification of etiology was based on surgeon interpretation of the clinical presentation, the radiographic findings, and the operative findings; therefore, the etiology of occlusion should be interpreted in this context.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataGiven the small number of patients, multivariate modeling was not considered appropriate.
“Given the small number of patients, we did not believe that multivariate modeling would be appropriate.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataEndovascular therapy has changed the management of acute mesenteric ischemia and offers measurable advantages.
“Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach.”
Quote in the paperSubstantial claim- Rests on an assumption: The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
Classified as probably not a substantial claim.
InterpretationreasoningA randomized trial for acute mesenteric ischemia would be challenging because of its infrequent occurrence and acute presentation.
“A randomized trial for this disease process would be challenging, given the relatively infrequent occurrence and acute presentation.”
Quote in the paperSubstantial claim- Rests on an assumption: Acute mesenteric ischemia is relatively infrequent, making it difficult for a single center to accumulate a large experience in a short period.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThrombotic occlusions are typically associated with higher mortality (70%) than embolic occlusions (54%), presumably because of a larger volume of ischemic bowel.
“Thrombotic occlusions are typically associated with a higher mortality (70%) compared with embolic occlusions (54%), presumably due to the large volume of bowel subjected to ischemia. 1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenA single-institution procedural database was queried for all consecutive cases of acute mesenteric ischemia treated between December 1999 and December 2008.
“A single-institutional procedural database was queried for all consecutive cases of AMI treated from December 1999 to December 2008.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataUsing endovascular therapy as the primary modality for acute mesenteric ischemia reduces complications and improves outcomes.
“Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.”
Quote in the paperSubstantial claim- Rests on an assumption: The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReported mortality for acute mesenteric ischemia ranges from 60% to 90%, and this rate has remained fairly constant over the past decade with little improvement.
“Contemporary results report mortality ranges of 60% to 90%, 2 and the mortality rate has remained fairly constant during the past decade, with little improvement in results.[3][4][5]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Bradbury, 1995, Mesenteric ischaemia: a multidisciplinary approach, Br J Surg source
Not checked in the free run.
- cites [3][4][5]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMultivariate analysis was not performed because of the low number of observed cases in each group.
“Multivariate analysis was not used secondary to the overall low number of observed cases within each group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAvoiding urgent laparotomy may reduce the secondary injury that follows the initial ischemic insult.
“Avoiding urgent laparotomy may limit the secondary injury after the initial ischemic insult.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningInitial endovascular revascularization may limit the initial ischemic insult and allow appropriate clinical resuscitation before surgical exploration.
“Initial endovascular revascularization may limit the initial ischemic insult and allow appropriate clinical resuscitation before surgical exploration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study was approved by an institutional review board.
“This study was an institutional review board-approved study evaluating current therapy for AMI.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationComputed tomography angiography allows the surgeon to use endovascular therapy before laparotomy and to assess abdominal contents.
“Computed tomography angiography affords the surgeon the opportunity to use endovascular therapy before laparotomy and also allows the clinician to assess the abdominal contents.14”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Shih, 2007, CTA and MRA in mesenteric ischemia, AJR Am J Roentgenol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSurgeon selection bias cannot be avoided in this study.
“Surgeon selection bias cannot be avoided.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenEndovascular revascularization may restore bowel perfusion more rapidly than open visceral exposure, surgical embolectomy, or surgical bypass grafting.
“In addition, endovascular revascularization could potentially restore bowel perfusion more rapidly than open visceral exposure, surgical embolectomy, or surgical bypass grafting.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenPatients with thrombotic or embolic acute mesenteric ischemia were included, while those with mesenteric venous thrombosis, nonocclusive mesenteric ischemia, aortic dissection with visceral ischemia, or visceral ischemia under an investigational device exemption protocol were excluded.
“Patients with thrombotic or embolic etiologies for AMI were included.Patients presenting with AMI secondary to the following conditions were excluded: mesenteric venous thrombosis, nonocclusive mesenteric ischemia, aortic dissections complicated by visceral ischemia, and visceral ischemia occurring as part of an investigational device exemption protocol.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningAvoiding laparotomy gives the opportunity to spare more bowel.
“I think that avoiding the insult of the laparotomy does give the opportunity to spare more bowel.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataUsing endovascular therapy as the primary modality for acute mesenteric ischemia reduces the need for laparotomy, reduces length of bowel resection, and limits acute renal and pulmonary failure.
“Using endovascular therapy as the primary modality for AMI reduces the need for laparotomy, reduces length of bowel resection, and limits acute renal and pulmonary failure.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningEndovascular therapy is just as good as open therapy.
“I think that endovascular therapy is just as good as open therapy.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataEndovascular therapy has altered the management of acute mesenteric ischemia, and there are measurable advantages to this approach.
“Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThis report provides details such as diagnostics, laboratory analysis, operative management, length of bowel resection, and postoperative complications that cannot be retrieved from large national databases.
“this report affords details such as diagnostics, laboratory analysis, operative management, length of bowel resection, and postoperative complications that cannot be retrieved from large national databases.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
“Multivariate analysis was not used secondary to the overall low number of observed cases within each group.”
“Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.”
The paper relies on this without support.
Acute mesenteric ischemia is relatively infrequent, making it difficult for a single center to accumulate a large experience in a short period.
“given the relative infrequency of this disease, it is difficult for any one center to obtain a large experience over a relatively short interval.”
The authors state this as an assumption.
There are unidentified cases of acute mesenteric ischemia in which the vascular surgery service did not evaluate the patient.
“presumably, there are unidentified cases of AMI in which the vascular surgery service did not evaluate the patient.”
The paper relies on this without support.
The variability and error in determining exact etiology is uniform across articles reporting outcomes for acute mesenteric ischemia.
“However, the variability and error associated with determining the exact etiology is uniform across articles reporting outcomes for AMI.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Endovascular therapy is associated with lower rates of mortality and bowel resection than the traditional open approach for patients with occlusion of the superior mesenteric artery.
“Some studies have shown that endovascular therapy is associated with lower rates of mortality and bowel resection than the traditional, open approach [11–13].”
From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [13]
The Results report lower observed mortality with endovascular therapy (39% vs 50%), but the overall difference was not statistically significant; a significant reduction was reported for successful endovascular treatment and for thrombotic occlusions. Table II reports less bowel resected, while the difference in the proportion with bowel requiring resection (84% vs 94%) was not significant. The cohort also included patients with celiac-plus-superior-mesenteric-artery occlusion, rather than only superior mesenteric artery occlusion. (LLM, conf=0.87)
Experimental — accuracy not yet measuredAll studies have shown a benefit for endovascular therapy compared to open surgery in terms of lower bowel resection rates and lower 30-day mortality rates.
“All studies have shown a benefit for endovascular therapy compared to open surgery in terms of lower bowel resection rates and lower 30-day mortality rates.”
From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [13]
The Results (page unavailable) report less bowel resected among patients requiring resection and numerically lower overall mortality with endovascular therapy (39% vs 50%), but say there was no overall survival benefit; a significant mortality reduction was limited to successful treatment or thrombotic occlusions. The Methods (page unavailable) define mortality as in-hospital deaths, not 30-day deaths. This single-center study also cannot establish what “all studies” found, and it reports bowel resection length rather than a lower bowel resection rate. (LLM, conf=0.88)
Experimental — accuracy not yet measuredArthurs et al. reported that 56 of 70 patients with acute mesenteric ischemia underwent initial endovascular treatment, with a high success rate and lower in-hospital mortality compared with open surgery (36% vs 50%; P < .05).
“a recent single-institution publication from the Cleveland Clinic by Arthurs et al 4 in which 56 of 70 patients with AMI underwent initial endovascular treatment.The group demonstrated a high success rate with only nine of 56 treatment failures and a lower in-hospital mortality rate with endovascular treatment of AMI compared to traditional open surgical treatment (36% vs 50%; P Ͻ .05).”
From Revascularization for acute mesenteric ischemia (2012) · cites this paper as [4]
Endovascular therapy for acute mesenteric ischemia has escalated dramatically at most institutions and has been associated with lower mortality than traditional open surgery.
“Over the last decade, the use of endovascular therapy for treatment of patients with AMI has escalated dramatically at most institutions and has been associated with lower mortality than traditional open surgical therapy.4,5”
From Revascularization for acute mesenteric ischemia (2012) · cites this paper as [4]
The higher mortality of arteriosclerotic occlusions compared to embolic occlusions is probably due to a larger and more poorly compensated bowel ischemia.
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
Arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P=0.11).
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included.
“Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included [8–11, 14, 25, 26].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
An increase in arteriosclerotic occlusions to the main etiology was observed in our study (49%).
“As with other authors in recent years, an increase in arteriosclerotic occlusions to the main etiology was also observed in our study (49%) [11, 17].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
Only arteriosclerotic occlusions were treated by ET, so the endovascular failure can be explained by the heavily calcified visceral aortas and mesenteric vessel orifices.
“In fact, only arteriosclerotic occlusions were treated by ET so that the endovascular failure can be explained by the heavily calcified visceral aortas and mesenteric vessel orifices [11, 23].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Renal-failure significance differs between abstract and table
MajorThe abstract reports P < .05 for the 27% versus 50% acute renal failure comparison, while Table III reports P = .14 for the same comparison.
“Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05).”
“Acute renal failure, % 27 50 .14Pulmonary failure, % 27 64 Ͻ.05”
Overall mortality comparison has two P values
MinorThe Results text gives P = .10 for the 39% versus 50% mortality comparison, whereas Table III gives P = .15.
“The overall mortality was 39% for endovascular therapy vs 50% for traditional therapy (P ϭ .10).”
“Mortality, % 39 50 .15”
Confidence-interval lower bounds differ
MinorFor the thrombotic AMI mortality odds ratio of 0.10, the abstract gives a confidence-interval lower bound of 0.10, but the Results section gives 0.17. The latter interval also excludes the reported point estimate.
“Endovascular therapy was associated with improved mortality in thrombotic AMI (odds ratio, 0.10; 95% confidence interval, 0.10-0.76;P < .05).”
“endovascular therapy significantly reduced the mortality for thrombotic occlusions (mortality, 33%; odds ratio, 0.10; 95% confidence interval, 0.17-0.76;P Ͻ .05)”
Lytic-therapy count and percentage disagree
MinorThe discussion says 28 of 56 endovascular patients received lytic therapy. That is 50%, not the stated 48%.
Reported 48 · recomputed 50
“56 patients underwent endovascular therapy altogether, 48%, or 28 patients, underwent lytic therapy.”
Extended-infusion count conflicts with duration percentages
MinorThe Results section says 36% received two days of infusion and 5% received three days-about 11 of the approximately 27-28 lytic-therapy patients. The discussion instead says about seven received two or more days.
“Duration of thrombolysis infusion was most commonly 1 day (58%), with 36% of patients receiving 2 days, and 5% receiving 3 days of infusion.”
“The majority of our patients received 1 day of therapy, and then there are about seven patients that received 2 or more days of infusion therapy.”
Cites
Systematic review of survival after acute mesenteric ischaemia according to disease aetiology
Schoots, I. G., Koffeman, G. I., Legemate, D. A., Levi, M., & van Gulik, T. M. (2004) · Journal of British Surgery · doi:10.1002/bjs.4459 · Cited by 502 · see citing works
Chronic mesenteric ischemia: open surgery versus percutaneous angioplasty and stenting
Kasirajan, K., O'Hara, P. J., Gray, B. H., Hertzer, N. R., Clair, D. G., Greenberg, R. K., Krajewski, L. P., Beven, E. G., & Ouriel, K. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.111808 · Cited by 275 · see citing works
Self-citationUnchanged high mortality rates from acute occlusive intestinal ischemia: six year review
Kassahun, W. T., Schulz, T., Richter, O., & Hauss, J. (2008) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-007-0263-5 · Cited by 262 · see citing works
Mesenteric ischaemia: A multidisciplinary approach
Bradbury, A. W., Brittenden, J., McBride, K., & Ruckley, C. V. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800821105 · Cited by 239 · see citing works
The clinical course of asymptomatic mesenteric arterial stenosis
Thomas, J. H., Blake, K., Pierce, G. E., Hermreck, A. S., & Seigel, E. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70263-0 · Cited by 231 · see citing works
Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia
Wyers, M. C., Powell, R. J., Nolan, B. W., & Cronenwett, J. L. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.10.047 · Cited by 165 · see citing works
Acosta, S., Ögren, M., Sternby, N.-H., Bergqvist, D., & Björck, M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000154269.52294.57 · Cited by 162 · see citing works
Failure to improve outcome in acute mesenteric ischaemia: seven-year review
Mamode, I. P. (1999) · The European Journal of Surgery · doi:10.1080/110241599750007054 · Cited by 154 · see citing works
Thrombolytic therapy for acute superior mesenteric artery occlusion
Schoots, I. G., Levi, M. M., Reekers, J. A., Lameris, J. S., & van Gulik, T. M. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000141719.24321.0b · Cited by 152 · see citing works
Long-term outcome after mesenteric artery reconstruction: a 37-year experience
Cho, J.-S., Carr, J. A., Jacobsen, G., Shepard, A. D., Nypaver, T. J., & Reddy, D. J. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.118593 · Cited by 145 · see citing works
Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia
Sarac, T. P., Altinel, O., Kashyap, V., Bena, J., Lyden, S., Sruvastava, S., Eagleton, M., & Clair, D. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.11.046 · Cited by 145 · see citing works
Self-citationCTA and MRA in Mesenteric Ischemia: Part 1, Role in Diagnosis and Differential Diagnosis
Shih, M.-C. P., & Hagspiel, K. D. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.05.1167 · Cited by 139 · see citing works
Acosta, S., Ögren, M., Sternby, N.-H., Bergqvist, D., & Björck, M. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2003.11.003 · Cited by 126 · see citing works
Yang, H. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i32.4112 · Cited by 10 · see citing works
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293 · see citing works
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658 · see citing works
Halliday, A. W., & Bax, J. J. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.03.004 · Cited by 654 · see citing works
Clair, D. G., & Beach, J. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1503884 · Cited by 589 · see citing works
Self-citationAcute mesenteric ischemia: guidelines of the World Society of Emergency Surgery
Bala, M., Kashuk, J., Moore, E. E., Kluger, Y., Biffl, W., Gomes, C. A., Ben-Ishay, O., Rubinstein, C., Balogh, Z. J., Civil, I., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0150-5 · Cited by 574 · see citing works
“There are no randomized controlled trials comparing laparotomy versus endovascular treatment as a first line strategy for the management AMI [10, 58, 59].”
MethodAcute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery.
Bala, M., Catena, F., Kashuk, J., De Simone, B., Gomes, C. A., Weber, D., Sartelli, M., Coccolini, F., Kluger, Y., Abu-Zidan, F. M., et al. (2022) · World Journal of Emergency Surgery · doi:10.1186/s13017-022-00443-x · Cited by 380 · see citing works
Gastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Lalošević, M. S., Milosavljević, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 315 · see citing works
“Studies by Schermerhon and Arthus showed that endovascular therapy is associated with lower mortality when compared to open revascularization (16% vs 28%) [97, 98] and is preferable in elderly who usually have a plethora of other co-morbidities making them poor candidates for open surgery.”
BackgroundAboyans, V., Ricco, J., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T. U., Collet, J., Czerny, M., Carlo, M. D., Debus, S., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.07.018 · Cited by 1,006 · see citing works
The Diagnosis of Acute Mesenteric Ischemia: A Systematic Review and Meta-analysis
Cudnik, M. T., Darbha, S., Jones, J., Macedo, J., Stockton, S. W., & Hiestand, B. C. (2013) · Academic Emergency Medicine · doi:10.1111/acem.12254 · Cited by 275 · see citing works
Nuzzo, A., Maggiori, L., Ronot, M., Becq, A., Plessier, A., Gault, N., Joly, F., Castier, Y., Vilgrain, V., Paugam, C., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.38 · Cited by 233 · see citing works
Comparison of open and endovascular treatment of acute mesenteric ischemia
Beaulieu, R. J., Arnaoutakis, K. D., Abularrage, C. J., Efron, D. T., Schneider, E., & Black, J. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.084 · Cited by 222 · see citing works
“While TPN infusion may occur independent of bowel resection (ie, as a method for providing bowel rest), Arthurs et al showed a significant increase in the length of small bowel resected in patients undergoing open revascularization for AMI (160 cm vs 59 cm), which may increase the risks of requiring TPN.15 Endovascula…”
BackgroundMethodInfluentialACR appropriateness criteria® imaging of mesenteric ischemia
Oliva, I. B., Davarpanah, A. H., Rybicki, F. J., Desjardins, B., Flamm, S. D., Francois, C. J., Gerhard-Herman, M. D., Kalva, S. P., Ashraf Mansour, M., Mohler, E. R., et al. (2013) · Abdominal Imaging · doi:10.1007/s00261-012-9975-2 · Cited by 200 · see citing works
Revascularization for acute mesenteric ischemia
Ryer, E. J., Kalra, M., Oderich, G. S., Duncan, A. A., Gloviczki, P., Cha, S., & Bower, T. C. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.12.017 · Cited by 188 · see citing works
Modern treatment of acute mesenteric ischaemia
Acosta, S., & Björck, M. (2013) · British journal of surgery · doi:10.1002/bjs.9330 · Cited by 183 · see citing works
Ogino, H., Iida, O., Akutsu, K., Chiba, Y., Hayashi, H., Ishibashi‐Ueda, H., Kaji, S., Kato, M., Komori, K., Matsuda, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0794 · Cited by 178 · see citing works
Current status on plasma biomarkers for acute mesenteric ischemia
Acosta, S., & Nilsson, T. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0660-z · Cited by 157 · see citing works
Klar, E., Rahmanian, P. B., Bücker, A., Hauenstein, K., Jauch, K., & Luther, B. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0249 · Cited by 162 · see citing works
“Because of patients’ high comorbidity rate (average age above 68 years) and the major access trauma of open vascular reconstruction, and thanks to the advances in endovascular techniques, indirect catheter techniques using transfemoral or transaxillary access should be favored when possible (12).”
BackgroundCorcos, O., Castier, Y., Sibert, A., Gaujoux, S., Ronot, M., Joly, F., Paugam, C., Bretagnol, F., Abdel–Rehim, M., Francis, F., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.027 · Cited by 142 · see citing works
Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis
Tamme, K., Reintam Blaser, A., Laisaar, K.-T., Mändul, M., Kals, J., Forbes, A., Kiss, O., Acosta, S., Bjørck, M., & Starkopf, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062846 · Cited by 112 · see citing works
Gastro-Intestinal Vascular Emergencies
Corcos, O., & Nuzzo, A. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.08.006 · Cited by 104 · see citing works
Koelemay, M. J., Geelkerken, R. H., Kärkkäinen, J., Leone, N., Antoniou, G. A., de Bruin, J. L., Gombert, A., Gottsätter, A., Iborra, E., Ronchey, S., et al. (2025) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2025.06.010 · Cited by 123 · see citing works
Oderich, G. S., Macedo, R., Stone, D. H., Woo, E. Y., Panneton, J. M., Resch, T., Dias, N. V., Sonesson, B., Schermerhorn, M. L., Lee, J. T., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.086 · Cited by 97 · see citing works
ACR appropriateness criteria® imaging of mesenteric ischemia
Ginsburg, M., Obara, P., Lambert, D. L., Hanley, M., Steigner, M. L., Camacho, M. A., Chandra, A., Chang, K. J., Gage, K. L., Peterson, C. M., et al. (2018) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2018.09.018 · Cited by 99 · see citing works
Serological biomarkers for acute mesenteric ischemia
Memet, O., Zhang, L., & Shen, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.51 · Cited by 87 · see citing works
Trends in treatment and mortality for mesenteric ischemia in the United States from 2000 to 2012
Zettervall, S. L., Lo, R. C., Soden, P. A., Deery, S. E., Ultee, K. H., Pinto, D. S., Wyers, M. C., & Schermerhorn, M. L. (2017) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.01.007 · Cited by 88 · see citing works
Acute type B aortic dissection complicated by visceral ischemia
Jonker, F. H. W., Patel, H. J., Upchurch, G. R., Williams, D. M., Montgomery, D. G., Gleason, T. G., Braverman, A. C., Sechtem, U. P., Fattori, R., Eusanio, M. D., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.012 · Cited by 89 · see citing works
Roussel, A., Castier, Y., Nuzzo, A., Pellenc, Q., Sibert, A., Panis, Y., Bouhnik, Y., & Corcos, O. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.06.204 · Cited by 92 · see citing works
Bobadilla, J. L. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.04.002 · Cited by 93 · see citing works
Contemporary Management of Acute Mesenteric Ischemia in the Endovascular Era
Lim, S., Halandras, P. M., Bechara, C. F., Aulivola, B., & Crisostomo, P. R. (2018) · Vascular and Endovascular Surgery · doi:10.1177/1538574418805228 · Cited by 92 · see citing works
Retrograde open mesenteric stenting for acute mesenteric ischemia
Blauw, J. T. M., Meerwaldt, R., Brusse-Keizer, M. G. J., Kolkman, J. J., Gerrits, D. G., & Geelkerken, R. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.001 · Cited by 83 · see citing works
Endovascular Therapy as a Primary Revascularization Modality in Acute Mesenteric Ischemia
Kärkkäinen, J. M., Lehtimäki, T. T., Saari, P., Hartikainen, J., Rantanen, T., Paajanen, H., & Manninen, H. (2015) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1064-9 · Cited by 77 · see citing works
The importance of open emergency surgery in the treatment of acute mesenteric ischemia
Duran, M., Pohl, E., Grabitz, K., Schelzig, H., Sagban, T. A., & Simon, F. (2015) · World Journal of Emergency Surgery · doi:10.1186/s13017-015-0041-6 · Cited by 76 · see citing works
“However, another study reported lower morbidity and mortality using the endovascular method [20].”
ResultRaupach, J., Lojík, M., Chovanec, V., Renc, O., Strýček, M., Dvorak, P., Hoffmann, P., Guňka, I., Ferko, A., Ryška, P., et al. (2015) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1156-6 · Cited by 71 · see citing works
Early Endovascular Treatment of Superior Mesenteric Occlusion Secondary to Thromboemboli
Jia, Z., Jiang, G., Tian, F., Zhao, J., Li, S., Wang, K., Wang, Y., Jiang, L., & Wang, W. (2013) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2013.09.025 · Cited by 69 · see citing works
Management of Acute Mesenteric Ischemia: A Critical Review and Treatment Algorithm
Zhao, Y., Yin, H., Yao, C., Deng, J., Wang, M., Li, Z., & Chang, G. (2016) · Vascular and Endovascular Surgery · doi:10.1177/1538574416639151 · Cited by 64 · see citing works
A study on 107 patients with acute mesenteric ischemia over 30 years
Alhan, E., Usta, A., Çekiç, A., Saglam, K., Türkyılmaz, S., & Cinel, A. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.07.011 · Cited by 63 · see citing works
Surgical management of peritonitis secondary to acute superior mesenteric artery occlusion
Acosta, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9936 · Cited by 64 · see citing works
“…al [22] 2009 United States 2000-2006 1857 (35) 2138 (41) 1615 (31) Block et al [18] 2010 Sweden 1999-2006 42 (26) 80 (51) 1 61 (37) Arthurs et al [23] 2011 Cleveland, OH, United States 1999-2008 56 (80) 60 (80) 29 (41) Ryer et al [24] 2012 Rochester, MI, United States 1990-2010 11 (12) 38 (41)…”
BackgroundThrombolysis for acute occlusion of the superior mesenteric artery
Björnsson, S., Björck, M., Block, T., Resch, T., & Acosta, S. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.054 · Cited by 63 · see citing works
“Several clinical tudies have also found an association between high plasma actate values and death.(3,21,22) Plasma D-dimer, however, as elevated in all measured cases, which confirms previous ndings that D-dimer is a highly sensitive test for acute ntestinal ischemia(6,23) but lacks specificity.”
BackgroundMethodResultInfluentialPlasma biomarkers for early diagnosis of acute intestinal ischemia
Powell, A., & Armstrong, P. (2014) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2015.01.008 · Cited by 60 · see citing works
Yang, S., Fan, X., Ding, W., Liu, B., Meng, J., Xu, D., He, C., Yu, W., Wu, X., & Li, J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.018 · Cited by 58 · see citing works
“It has shown measurable advantages to traditional open treatment for AMI, and become the central part of the multidisciplinary stepwise management strategy [29–31].”
Knowles, M., Nation, D. A., Timaran, D. E., Gomez, L. F., Baig, M. S., Valentine, R. J., & Timaran, C. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.06.113 · Cited by 60 · see citing works
Carver, T. W., Vora, R. S., & Taneja, A. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2015.11.001 · Cited by 58 · see citing works
Sgroi, M. D., Kabutey, N.-K., Krishnam, M. S., et al. (2014) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.05.020 · Cited by 56 · see citing works
Evolution in the Presentation, Treatment, and Outcomes of Patients with Acute Mesenteric Ischemia
Chou, E. L., Wang, L. J., McLellan, R. M., Feldman, Z. M., Latz, C. A., LaMuraglia, G. M., Clouse, W. D., Eagleton, M. J., & Conrad, M. F. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.01.116 · Cited by 51 · see citing works
Self-citationEslami, M. H., Rybin, D. V., Doros, G. D., McPhee, J. T., & Farber, A. M. (2015) · Vascular · doi:10.1177/1708538115577730 · Cited by 54 · see citing works
“In the work presented here the overall mortality rates were significantly better than previously reported rates of 50–80%.(2,3,14,16) But our work suggests that even though majority of these procedures were performed using endovascular procedures, the mortality rates have remained unchanged in the last decade.”
BackgroundResultTolonen, M., Lemma, A., Vikatmaa, P., Peltola, E., Mentula, P., Björkman, P., Leppäniemi, A., & Sallinen, V. (2021) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000003305 · Cited by 46 · see citing works
Outcomes of antegrade and retrograde open mesenteric bypass for acute mesenteric ischemia
Scali, S. T., Ayo, D., Giles, K. A., Gray, S. E., Kubilis, P. S., Back, M. R., Fatima, J., Arnaoutakis, D. J., Berceli, S. A., Beck, A. W., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.04.063 · Cited by 52 · see citing works
Salsano, G., Salsano, A., Sportelli, E., Petrocelli, F., Dahmane, M., Spinella, G., Pane, B., Mambrini, S., Palombo, D., & Santini, F. (2018) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-017-1749-3 · Cited by 52 · see citing works
“It should also be underscored that in case of endovascular failure with suboptimal revascularization, surgical approach is not yet precluded and a second-look operation does not appear to increase in-hospital mortality [10].”
InfluentialUrine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients
Salim, S. Y., Young, P. Y., Churchill, T. A., & Khadaroo, R. G. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2016.07.017 · Cited by 48 · see citing works
Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience
Freitas, B., Bausback, Y., Schuster, J., Ülrich, M., Bräunlich, S., Schmidt, A., & Scheinert, D. (2018) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.11.041 · Cited by 49 · see citing works
Acute mesenteric ischemia (Part II) – Vascular and endovascular surgical approaches
Kärkkäinen, J. M., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.11.003 · Cited by 48 · see citing works
Systematic review and meta-analysis of endovascular treatment for acute mesenteric ischaemia
El Farargy, M., Abdel Hadi, A., Abou Eisha, M., Bashaeb, K., & Antoniou, G. A. (2017) · Vascular · doi:10.1177/1708538116689353 · Cited by 43 · see citing works
“An increased co-morbid burden, poor collateral circulation and a delayed diagnosis are some of the suggested predictors of poor outcomes.(4,5,9,18) Recanalisation has been recommended even in those patients with delayed presentation, especially those with thrombotic mesenteric disease.”
BackgroundEndovascular therapy for acute mesenteric ischemia: an NSQIP analysis
Branco, B. C., Montero-Baker, M. F., Aziz, H., Taylor, Z., & Mills, J. L. (2015) · The American Surgeon™ · doi:10.1177/000313481508101131 · Cited by 43 · see citing works
Erben, Y., Protack, C. D., Jean, R. A., Sumpio, B. J., Miller, S. M., Liu, S., Trejo, G., & Sumpio, B. E. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.078 · Cited by 40 · see citing works
“However, in recent years, endovascular treatment has gained popularity in the management of this lethal disease.(4,5) This trend in endovascular therapy has been observed in several large database analyses and metaanalyses; despite the continued predilection for open revascularization (OPEN), endovascular techniques (…”
BackgroundZhang, Z., Wang, D., Li, G., Wang, X., Wang, Y., Li, G., & Jiang, T. (2017) · BioMed Research International · doi:10.1155/2017/1964765 · Cited by 39 · see citing works
Najdawi, M., Garzelli, L., Nuzzo, A., Huguet, A., Raynaud, L., Paulatto, L., Panis, Y., Ben Abdallah, I., Castier, Y., Sibert, A., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08660-3 · Cited by 38 · see citing works
“The rate of intestinal resection varies in the literature, from 14.4% of patients who underwent endovascular procedures in the series by Beaulieu et al [2] to 69% in that by Arthurs et al [3].”
BackgroundMethodInfluentialACR Appropriateness Criteria ® Radiologic Management of Mesenteric Ischemia
Fidelman, N. A., AbuRahma, A. F., Cash, B. D., Kapoor, B. S., Knuttinen, M. G., Minocha, J., Rochon, P. J., Shaw, C. M., Ray, C. E., & Lorenz, J. M. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.02.014 · Cited by 37 · see citing works
The role of endovascular therapy in acute mesenteric ischemia
Ierardi, A. M. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0164 · Cited by 37 · see citing works
“Arthurs 2011 [8] 56 35% 65% 0% Abdominal pain 92%, Nausea 69%, Emesis 51%, Bloody diarrhea 31% SMA 66% SMA+ celiac artery 34% 48% 11% 32%”
BackgroundInfluentialResults of retrograde open mesenteric stenting for acute thrombotic mesenteric ischemia
Roussel, A., Schiava, N. D., Coscas, R., Pellenc, Q., Boudjelit, T., Goëau-Brissonnière, O., Corcos, O., Lermusiaux, P., Coggia, M., & Castier, Y. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.07.058 · Cited by 38 · see citing works
Mesenteric vascular treatment 2016: from open surgical repair to endovascular revascularization
Blauw, J. T. M., Bulut, T., Oderich, G. S., & Geelkerken, B. R. H. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.01.002 · Cited by 36 · see citing works
Björck, M., Orr, N., & Endean, E. D. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.04.431 · Cited by 35 · see citing works
High risk and low prevalence diseases: Mesenteric ischemia
Molyneux, K., Beck‐Esmay, J., Koyfman, A., & Long, B. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.01.001 · Cited by 35 · see citing works
Percutaneous mechanical thrombectomy of superior mesenteric artery embolism
Kuhelj, D., Kavčič, P., & Popovič, P. (2013) · Radiology and Oncology · doi:10.2478/raon-2013-0029 · Cited by 32 · see citing works
Ding, W., Wang, K., Liu, B., Fan, X., Wang, S., Cao, J., Wu, X., & Li, J. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000799 · Cited by 31 · see citing works
Mendes, B. C., Oderich, G. S., Tallarita, T., Kanamori, K. S., Kalra, M., DeMartino, R. R., Shuja, F., & Johnstone, J. K. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.12.076 · Cited by 32 · see citing works
Arterial thrombosis in unusual sites: A practical review
O’Donnell, M., Shatzel, J. J., Olson, S. R., Daughety, M. M., Nguyen, K. P., Hum, J., & DeLoughery, T. G. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13165 · Cited by 28 · see citing works
Mesenteric ischemia: a radiologic perspective
Sinha, D., Kale, S. K., Kundaragi, N. G., & Sharma, S. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02867-y · Cited by 26 · see citing works
Atre, I. D., Eurboonyanun, K., O’Shea, A., Lahoud, R. M., Shih, A. R., Kalva, S. P., Harisinghani, M. G., & Hedgire, S. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02558-8 · Cited by 27 · see citing works
“demonstrated that the use of EVT as the primary modality for AMI reduces complications with improved outcomes [25].”
Acute mesenteric ischemia in elderly patients
Kärkkäinen, J. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1212657 · Cited by 28 · see citing works
Yang, S., Zhang, L., Liu, K., Fan, X., Ding, W., He, C., Wu, X., & Li, J. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2016.02.019 · Cited by 27 · see citing works
Open and endovascular management of acute mesenteric ischaemia: a systematic review
Murphy, B., Dejong, C. H. C., & Winter, D. C. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05149-x · Cited by 27 · see citing works
“Supporting this, Arthurs et al. [9] found that patients who underwent open surgery trended towards a higher serum lactate measurement than the endovascular group.”
BackgroundResultInfluentialRabuffi, P., Vagnarelli, S., Bruni, A. D. C., et al. (2019) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-019-02354-y · Cited by 27 · see citing works
Arya, S., Kingman, S., Knepper, J. P., Eliason, J. L., Henke, P. K., & Rectenwald, J. E. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.07.038 · Cited by 26 · see citing works
Lendzion, R. J., Frahm‐Jensen, G., & Keck, J. O. (2022) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0042-1743283 · Cited by 30 · see citing works
Аlexander, K., Ismail, M., Alexander, M., Ivan, T., Olga, V., Dmitry, S., Головина, А. А., & Андреевич, М. Д. (2019) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2019.07.077 · Cited by 25 · see citing works
Is open surgery or endovascular therapy best to treat acute mesenteric occlusive disease?
Smith, S. F., Gollop, N. D., Klimach, S. G., & Murray, P. J. (2013) · International Journal of Surgery · doi:10.1016/j.ijsu.2013.10.003 · Cited by 21 · see citing works
A Shifting Trend Towards Endovascular Intervention in the Treatment of Acute Mesenteric Ischemia
Naazar, A. A., Omair, A., Chu, S. H., Keane, K. G., & Weber, D. G. (2021) · Cureus · doi:10.7759/cureus.18544 · Cited by 24 · see citing works
Li, W., Cao, S., Zhang, Z., Zhu, R., Chen, X., Liu, B., & Feng, H. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.833464 · Cited by 25 · see citing works
“Other studies (11, 15) reported that increasing age, history of peripheral arterial disease, coronary artery disease, initial lactate >2.”
BackgroundInfluentialGarzelli, L., Nuzzo, A., Hamon, A., Abdallah, I. B., Grégory, J., Raynaud, L., Paulatto, L., Burgio, M. D., Castier, Y., Panis, Y. H., et al. (2022) · Insights into Imaging · doi:10.1186/s13244-022-01339-9 · Cited by 22 · see citing works
Swerdlow, N. J., Varkevisser, R. R. B., Soden, P. A., Zettervall, S. L., McCallum, J. C., Li, C., Wyers, M. C., & Schermerhorn, M. L. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.05.024 · Cited by 22 · see citing works
Mesenteric ischemia in acute aortic dissection
Orihashi, K. (2018) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-018-0970-6 · Cited by 21 · see citing works
Orr, N. T., & Endean, E. D. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.04.026 · Cited by 18 · see citing works
Shi, Y., Zhao, B., Zhou, Y., Chen, L., Su, H., & Gu, J. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.07.084 · Cited by 21 · see citing works
Engineered Vasculature for Cancer Research and Regenerative Medicine
Nguyen, H. T., Peirsman, A., Tirpáková, Z., Mandal, K., Vanlauwe, F., Maity, S., Kawakita, S., Khorsandi, D., Herculano, R. D., Umemura, C., et al. (2023) · Micromachines · doi:10.3390/mi14050978 · Cited by 19 · see citing works
Tual, A., Garzelli, L., Nuzzo, A., Corcos, O., Castier, Y., Abdallah, I. B., & Ronot, M. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.01.041 · Cited by 19 · see citing works
Zhuang, X., Chen, F., Zhou, Q., Zhu, Y., & Yang, X. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01746-0 · Cited by 15 · see citing works
Mesenteric ischemia in acute aortic dissection
Orihashi, K. (2015) · Surgery Today · doi:10.1007/s00595-015-1193-4 · Cited by 20 · see citing works
“Favorable results after endovascular treatment have been reported [33, 34], and retrospective analysis has shown results equal to or better than those of conventional surgical treatment [35].”
ResultAcute mesenteric ischemia of arterial origin: Importance of early revascularization
Plumereau, F., Mucci, S., Naoures, P. L., Finel, J.-B., & Hamy, A. (2015) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.11.001 · Cited by 21 · see citing works
Yang, S., Wu, X., & Li, J. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.03.015 · Cited by 20 · see citing works
Local thrombolytic therapy in acute mesenteric ischemia
Yanar, F., Agcaoglu, O., Sarici, I. S., Sivrikoz, E., Ucar, A., Yanar, H., Aksoy, M., & Kurtoglu, M. (2013) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-8-8 · Cited by 19 · see citing works
“Thrombolytic therapy is an effective and quick treatment modality for AMI and may obviate surgery and has the potential to resolve the clot completely [15,16].”
Pengermä, P., Venesmaa, S., Karjalainen, J., Ukkonen, M., Saari, P., & Kärkkäinen, J. M. (2023) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2023.08.100 · Cited by 19 · see citing works
Zhang, Z., Chen, X., Li, C., Feng, H., Yu, H., & Zhu, R. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.08.096 · Cited by 20 · see citing works
Acute mesenteric ischaemia: imaging and intervention
Hawthorn, B. R., & Ratnam, L. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.06.001 · Cited by 18 · see citing works
Chirurgie des artères digestives
Marzelle, J., Brunetti, F., Cochennec, F., & Becquemin, J.-P. (2013) · EMC - Techniques chirurgicales - Chirurgie vasculaire · doi:10.1016/s0246-0459(12)60874-0 · Cited by 17 · see citing works
Midterm Clinical Outcomes of Retrograde Open Mesenteric Stenting for Mesenteric Ischemia
Cirillo-Penn, N. C., DeMartino, R. R., Rasmussen, T. E., Shuja, F., Colglazier, J. J., Kalra, M., Oderich, G. S., & Mendes, B. C. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.09.062 · Cited by 17 · see citing works
Garzelli, L., Dufay, R., Tual, A., Corcos, O., Cazals-Hatem, D., Vilgrain, V., Nuzzo, A., Ben Abdallah, I., & Ronot, M. (2024) · Radiology · doi:10.1148/radiol.230830 · Cited by 17 · see citing works
Antibiotic use in acute mesenteric ischemia: A review of the evidence and call to action
Tian, Y., Dhara, S., Barrett, C. D., Richman, A. P., & Brahmbhatt, T. S. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00486-3 · Cited by 17 · see citing works
“A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia [13] 2011 1999–2008 Retrospective Single Institution 70 Not mentioned.”
BackgroundMethodAcute and Chronic Ischemic Disorders of the Small Bowel
Prakash, V., Marin, M. L., & Faries, P. L. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0694-5 · Cited by 17 · see citing works
The Use of AngioVac for Symptomatic Aortic Thrombus Complicated by Mesenteric Ischemia
Monastiriotis, S., Gonzales, C. F., Kokkosis, A. A., et al. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.09.026 · Cited by 17 · see citing works
Zientara, A., Domenghino, A.-R., Schwegler, I., Bruijnen, H., Schnider, A., Weber, M., Gutknecht, S., & Attigah, N. (2021) · BMC Surgery · doi:10.1186/s12893-021-01102-9 · Cited by 18 · see citing works
- Authors
- Arthurs, Z. M., Titus, J., Bannazadeh, M., Eagleton, M. J., Srivastava, S., Sarac, T. P., & Clair, D. G.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Arthurs, Zachary M.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 53
- Issue
- 3
- Pages
- 698-705
- ISSN
- 0741-5214 (ISSN-L)
- OpenAlex
- W2146977838
- Cited by
- 285
- References
- 15
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 13 · 2023: 23 · 2022: 14 · 2021: 16 · 2020: 19 · 2019: 25 · 2018: 19 · 2017: 29 · 2016: 18 · 2015: 26 · 2014: 21 · 2013: 19 · 2012: 10
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Vascular Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
- Health Sciences › Medicine › Surgery › Intestinal and Peritoneal Adhesions
- Keywords
- acute mesenteric ischemia, endovascular revascularization, mesenteric artery occlusion, bowel resection, in-hospital mortality, acute kidney injury, respiratory failure, surgical treatment
- MeSH terms
- Aged, Angioplasty, Balloon, Embolism, Female, Humans, Ischemia, Male, Mesenteric Vascular Occlusion, Middle Aged, Ohio, Respiratory Insufficiency, Retrospective Studies, Risk Factors, Thrombosis, Time Factors, Vascular Diseases, Vascular Surgical Procedures, Thrombolytic Therapy, Chi-Square Distribution, Odds Ratio, Treatment Outcome, Hospital Mortality, Embolectomy, Thrombectomy, Risk Assessment, Endovascular Procedures, Vascular Grafting, Acute Kidney Injury, Mesenteric Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-01.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-01.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
